Influx Healthtech IPO: Check GMP, Day One Subscription Status, Price Band And More
Influx Healthtech IPO is a book-building offer worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh shares and an offer-for-sale (OFS) of 11 lakh shares.
Influx Healthtech Ltd. launched its initial public offering (IPO) on Wednesday to raise more than Rs 55 crore from the primary market.
The company is primarily engaged in contract manufacturing for pharma companies. Investors who want to bid for shares in the IPO should check the important details about the NSE SME issue before submitting their bids.
Influx Healthtech IPO: Key Details
The Influx Healthtech IPO is a book-building issue worth Rs 55.63 crore. It comprises a fresh issue of 46.94 lakh shares, worth Rs 45.07 crore, and an offer-for-sale of 11 lakh shares, amounting to Rs 10.56 crore.
Retail investors can invest in the IPO by bidding for a single lot size of 1200 shares, requiring an investment of Rs 1,15,200. High Net-Worth Individuals (HNIs) have to bid for two lots comprising 2,400 shares, amounting to an investment of Rs 2,30,400.
The price band for the IPO has been fixed between Rs 91 and Rs 96 per share.
The Influx Healthtech IPO is open for subscription from June 18 to June 20. The allotment of shares is scheduled to be finalised on June 23. Successful bidders will receive the shares in their Demat accounts on June 24. Refunds for non-allottees will also be processed on the same day.
Influx Healthtech's IPO listing is scheduled for June 25. Shares of Influx Healthtech Ltd. will be listed on the NSE SME platform.
Rarever Financial Advisors Pvt. is the book-running lead manager of the Influx Healthtech IPO. Maashitla Securities Pvt. is the registrar and RK Stock Holding Pvt. is the market maker for the issue.
Influx Healthtech IPO Subscription Status
The Influx Healthtech IPO has been subscribed 1.50 times as of 12:02 p.m. on Wednesday.
Qualified Institutional Buyers: nil
Non-Institutional Investors: 1.26 times
Retail Investors: 2.45 times
*The subscription status will be updated at regular intervals
Influx Healthtech IPO GMP Today
According to InvestorGain, the grey market premium (GMP) for the Influx Healthtech IPO was Rs 42 as of 10:50 a.m. on June 18. The latest GMP indicates it will list at Rs 138 per share, at a premium of 43.75% apiece on the upper end of the price band.
Note: GMP does not represent official data and is based on speculation.
Influx Healthtech Business And Financials
The company is a manufacturer of healthcare products. Its portfolio includes nutraceuticals, cosmetics, Ayurvedic and veterinary feed supplements.
Use Of Proceeds
The company will use proceeds from the IPO to set up manufacturing facilities, buy machinery and for general corporate purposes.
Financials
The company’s profit after tax (PAT) rose 20.1% year-on-year (YoY) to Rs 13.37 crore in FY25 from Rs 11.13 crore in FY24. Revenue from operations increased 4.9% YoY to Rs 104.85 crore in FY25 from Rs 99.96 crore in FY24.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
